Back to TVTX

ARMISTICE CAPITAL, LLC → TVTX

ARMISTICE CAPITAL, LLC TVTX Position History

Travere Therapeutics, Inc. • Healthcare

Quarters held
7
Latest value
$42.4M
Q3 2026
Peak value
$160.7M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$160.7M
Q4 2025$143.8M
Q1 2026$145.5M
Q2 2026$89.3M
Q2 2026$28.4M
Q3 2026$75.9M
Q3 2026$42.4M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$42.4M720.0K——
Q3 2026$75.9M1.29M——
Q2 2026$28.4M500.0K——
Q2 2026$89.3M1.57M——
Q1 2026$145.5M4.90M——
Q4 2025$143.8M3.76M——
Q3 2025$160.7M6.72M——

Other funds holding TVTX

Other ARMISTICE CAPITAL, LLC positions

PTCT

PTC THERAPEUTICS INC

$212.8M
PTCT

PTC THERAPEUTICS ORD

$201.1M
IMVT

IMMUNOVANT INC

$146.1M
PTCT

PTC THERAPEUTICS INC

$141.3M
SUPN

SUPERNUS PHARMACEUTICALS INC

$137.4M
SUPN

SUPERNUS PHARMACEUTICALS ORD

$135.5M
SUPN

SUPERNUS PHARMACEUTICALS

$123.1M
NBIX

NEUROCRINE BIOSCIENCES INC

$116.3M